Hemoglobin A1c and glucose criteria identify different subjects as having type 2 diabetes in middle-aged and older populations: The KORA S4/F4 Study

References

• World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus. Report of a WHO consultation. Geneva: World Health Organization; 1999.
   Google Scholar
• Borch-Johnsen K, Colagiuri S. Diagnosing diabetes—time for a change? Diabetologia. 2009;52:2247–50.
   PubMed Web of Science ®Google Scholar
• Consensus Committee. Consensus Statement on the Worldwide Standardization of the Hemoglobin A1C Measurement: the American Diabetes Association, European Association for the Study of Diabetes, International Federation of Clinical Chemistry and Laboratory Medicine, and the International Diabetes Federation. Diabetes Care. 2007;30:2399–400.
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Standards of Medical Care in Diabetes—2010. Diabetes Care. 2010;33:S11–61.
   PubMed Web of Science ®Google Scholar
• International Expert Committee. International Expert Committee Report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care. 2009;32:1327–34.
   PubMed Web of Science ®Google Scholar
• Christensen DL, Witte DR, Kaduka L, Jørgensen ME, Borch-Johnsen K, Mohan V, . Moving to an A1C-based diagnosis of diabetes has a different impact on prevalence in different ethnic groups. Diabetes Care. 2010;33:580–2.
   Web of Science ®Google Scholar
• Davidson MB, Schriger DL. Effect of age and race/ethnicity on HbA1c levels in people without known diabetes mellitus: implications for the diagnosis of diabetes. Diabetes Res Clin Pract. 2010;87:415–21.
   PubMed Web of Science ®Google Scholar
• Rathmann W, Haastert B, Icks A, Löwel H, Meisinger C, Holle R, . High prevalence of undiagnosed diabetes mellitus in Southern Germany: Target populations for efficient screening. The KORA survey 2000. Diabetologia. 2003;46:182–9.
   Google Scholar
• Van't Riet E, Alssema M, Rijkelijkhuizen JM, Kostense PJ, Nijpels G, Dekker JM. Relationship between A1C and glucose levels in the general Dutch population. The New Hoorn Study. Diabetes Care. 2010;33:61–6.
   Google Scholar
• Kramer CK, Araneta MRG, Barrett-Connor E. A1C and diabetes diagnosis: The Rancho Bernardo Study. Diabetes Care. 2010;33:101–3.
   Google Scholar
• Zhou X, Pang Z, Gao W, Wang S, Zhang L, Ning F, . Performance of an A1C and fasting capillary blood glucose test for screening newly diagnosed diabetes and prediabetes defined by an oral glucose tolerance test in Quingdao, China. Diabetes Care. 2010;33:545–50.
   PubMed Web of Science ®Google Scholar
• Lorenzo C, Haffner SM. Performance characteristics of the new definition of diabetes. The Insulin Resistance Atherosclerosis Study. Diabetes Care. 2010;33:335–7.
   Google Scholar
• Cowie CC, Rust KF, Byrd-Holt DD, Gregg EW, Ford ES, Geiss LS, . Prevalence of diabetes and high risk for diabetes using A1C criteria in the US population in 1988-2006. Diabetes Care. 2010;33:562–8.
   PubMed Web of Science ®Google Scholar
• Bennett CM, Guo M, Dharmage SC. HbA1C as a screening tool for detection of Type 2 diabetes: a systematic review. Diabet Med. 2007;24:333–43.
   PubMed Web of Science ®Google Scholar
• Buell C, Kermah D, Davidson MB. Utility of A1C for Diabetes Screening in the 1999–2004 NHANES population. Diabetes Care. 2007;30:2233–5.
   PubMedGoogle Scholar
• Mohan V, Vijayachandrika V, Gokulakrishnan K, Anjana RM, Ganesan A, Weber MB, . A1C cut points to define various glucose intolerance groups in Asian Indians. Diabetes Care. 2010;33:515–9.
   PubMed Web of Science ®Google Scholar
• Lorenzo C, Wagenknecht LE, Hanley AJG, Rewers MJ, Karter AJ, Haffner SM. A1C between 5.7 and 6.4% as a marker for identifying pre-diabetes, insulin sensitivity and secretion, and cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study (IRAS). Diabetes Care. 2010;33:2104–9.
   PubMed Web of Science ®Google Scholar
• Mannucci E, Ognibene A, Sposato I, Brogi M, Gallori G, Bardini G, . Fasting plasma glucose and glycated haemoglobin in the screening of diabetes and impaired glucose tolerance. Acta Diabetol. 2003;40:181–6.
   Google Scholar
• Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, .; Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344:1343–50.
   PubMed Web of Science ®Google Scholar
• Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, .; Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393–403.
   PubMed Web of Science ®Google Scholar
• Borg R, Vistisen D, Witte DR, Borch-Johnsen K. Comparing risk profiles of individuals diagnosed by OGTT and HbA1c. Diabet Med. 2010;27:906–10.
   Google Scholar
• Mostafa SA, Davies MJ, Webb D, Gray LJ, Srinivasan BT, Jarvis J, . The potential impact of using glycated haemoglobin as the preferred diagnostic tool for detecting type 2 diabetes mellitus. Diabet Med. 2010;27:762–9.
   PubMedGoogle Scholar